Results 21 to 30 of about 305,628 (395)
Mortality of Patients Infected by COVID-19 with and without Deep-Vein Thrombosis
Medicines, 2021 Background: Current evidence points to a state of hypercoagulability (consequence of hyperinflammation) as an important pathogenic mechanism that contributes to the increase in mortality in cases of COVID-19.
Jose Maria Pereira de Godoy +7 more
doaj +1 more source
The Lancet, 2005 Deep vein thrombosis and its sequelae pulmonary embolism and post-thrombotic syndrome are some of the most common disorders. A thrombus either arises spontaneously or is caused by clinical conditions including surgery, trauma, or prolonged bed rest. In these instances, prophylaxis with low-dose anticoagulation is effective.
Paul A, Kyrle, Sabine, Eichinger
+6 more sources
Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality
TH Open, 2019 Background Many cardiovascular conditions exhibit seasonality in occurrence and mortality, but little is known about the seasonality of venous thromboembolism.
Nils Skajaa +5 more
doaj +1 more source
Upper extremity deep venous thrombosis: risk factors, diagnosis, treatment [PDF]
Romanian Journal of Medical Practice, 2016 Upper extremity deep venous thrombosis is a condition with increasing prevalence, with high risk of morbidity and mortality, due to embolic complications.
Camelia C. DIACONU +2 more
doaj +1 more source
AAOHN Journal, 2008 This article reviews the incidence, causes, risk factors, diagnosis, treatment, complications, and prevention of deep vein thrombosis (DVT). Various employees, including long-distance drivers or travelers, sedentary office workers, females taking estrogen, those who are obese, those who have cancer, and those who are hospitalized, may be at risk for ...
openaire +2 more sources
Incomplete Resolution of Deep Vein Thromboses during Rivaroxaban Therapy. [PDF]
, 2017 We present the case of a patient with a deep vein thrombosis (DVT) who failed rivaroxaban therapy. Our patient initially presented with left lower extremity edema, erythema, and pain.
Adashek, Jacob +6 more
core +5 more sources
Septic deep vein thrombosis [PDF]
Journal of Vascular Surgery, 1986 Anticoagulation is the cornerstone in the treatment of deep vein thrombosis. However, the treatment of septic deep vein thrombosis is controversial. Unlike septic superficial vein thrombosis, venous excision is often associated with limb-threatening or even life-threatening complications.
A K, Ang, O W, Brown
openaire +2 more sources
СОВРЕМЕННЫЙ ПОДХОД В ЛЕЧЕНИИ ОСТРОГО ТРОМБОЗА ГЛУБОКИХ ВЕН ПРЕПАРАТОМ РИВАРОКСАБАН
Архивъ внутренней медицины, 2015 Aim of prospective clinical study was to evaluate effectiveness, safety and convenience of treatment deep vein thrombosis with oral anticoagulant — Rivaroxaban from the 1st day of treatment.
Е. П. Кривощеко в +1 more
doaj +1 more source
Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. [PDF]
, 2018 It is common knowledge that cancer patients are more prone to develop venous thromboembolic complications (VTE). It is therefore not surprising that patients with hepatocellular carcinoma (HCC) present with a significant risk of VTE, with the portal vein
Burra, P +5 more
core +1 more source
PLoS ONE, 2013 Deep vein thrombosis is one of the common complications of orthopedic surgery. Studies indicated that genetic factors played a considerable role in the pathogenesis of deep vein thrombosis.
Jizheng Qin +7 more
doaj +1 more source